Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study
- PMID: 26896103
- PMCID: PMC8404160
- DOI: 10.1007/s40615-015-0109-8
Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study
Abstract
Purpose: Racial differences in prostate cancer treatment patterns have motivated concerns about over- and undertreatment. We surveyed black and white patients with localized prostate cancer (LPC) regarding their treatment decision-making processes to gain a better perspective on factors associated with LPC treatment choice.
Methods: We conducted a population-based, cross-sectional survey of 260 men (132 black, 128 white) aged ≤75 years, with newly diagnosed LPC. Our primary outcome was treatment choice (either surgery, radiation, or watchful waiting/active surveillance (WW/AS)), and our primary predictors were race and tumor risk level.
Results: Overall, treatment choice did not differ by race. As cancer risk increased, both black and white patients were more likely to undergo surgery and less likely to receive radiation. However, the pattern of WW/AS was different between white and black men. White men were less likely to select WW/AS as cancer risk increased, while risk level was unrelated to black men undergoing WW/AS. Urologist's recommendation had the greatest impact on men's treatment choice, followed by tumor risk level, age, and personal preferences.
Conclusions: Although there were no overall racial differences in treatment choice, when stratified by tumor risk level, the pattern of WW/AS was different between white and black patients, suggesting that over- and undertreatment is a larger concern for black than white men. A risk-stratified approach to understand racial disparities in LPC treatment and better strategies to aid black men in their treatment decision-making are needed to reduce racial disparities in prostate cancer outcomes.
Keywords: Active surveillance/watchful waiting; Prostate cancer; Prostatectomy; Racial differences; Radiation; Treatment decision-making.
Conflict of interest statement
Figures
Similar articles
-
Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.J Am Board Fam Med. 2017 May-Jun;30(3):288-297. doi: 10.3122/jabfm.2017.03.160298. J Am Board Fam Med. 2017. PMID: 28484061
-
Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.Ann Fam Med. 2022 Apr 1;20(20 Suppl 1):2917. doi: 10.1370/afm.20.s1.2917. Ann Fam Med. 2022. PMID: 36696653 Free PMC article.
-
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.J Gen Intern Med. 2004 Feb;19(2):146-55. doi: 10.1111/j.1525-1497.2004.30209.x. J Gen Intern Med. 2004. PMID: 15009794 Free PMC article.
-
The impact of ethnicity on decisions and decision making in prostate cancer: an integrative review.Ethn Health. 2025 Feb;30(2):316-336. doi: 10.1080/13557858.2024.2429416. Epub 2024 Nov 19. Ethn Health. 2025. PMID: 39560506 Review.
-
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.Nat Rev Urol. 2025 Apr;22(4):223-234. doi: 10.1038/s41585-024-00948-x. Epub 2024 Oct 18. Nat Rev Urol. 2025. PMID: 39424981 Review.
Cited by
-
Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.Ann Fam Med. 2016 May;14(3):208-14. doi: 10.1370/afm.1926. Ann Fam Med. 2016. PMID: 27184990 Free PMC article.
-
A Review of Research on Disparities in the Care of Black and White Patients With Cancer in Detroit.Front Oncol. 2021 Jul 7;11:690390. doi: 10.3389/fonc.2021.690390. eCollection 2021. Front Oncol. 2021. PMID: 34336677 Free PMC article. Review.
-
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapy.Arab J Urol. 2022 Nov 21;21(3):135-141. doi: 10.1080/2090598X.2022.2148867. eCollection 2023. Arab J Urol. 2022. PMID: 37521449 Free PMC article.
-
Active surveillance for low-risk localized prostate cancer: what do men and their partners think?Fam Pract. 2017 Feb;34(1):90-97. doi: 10.1093/fampra/cmw123. Epub 2016 Dec 29. Fam Pract. 2017. PMID: 28034917 Free PMC article.
-
Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system.Int J Urol. 2017 Oct;24(10):765-770. doi: 10.1111/iju.13424. Epub 2017 Sep 15. Int J Urol. 2017. PMID: 28913849 Free PMC article.
References
-
- Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: Cancer J Clin. 2011;61(4):212–36. - PubMed
-
- Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274(20):1599–605. - PubMed
-
- Underwood W 3rd, Wei J, Rubin MA, Montie JE, Resh J, Sanda MG. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity. Urol Oncol. 2004;22(1):20–4. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials